The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Increased excretion of a lipid peroxidation biomarker in autism
Abstract
It is thought that autism could result from an interaction between genetic and environmental factors with oxidative stress as a potential mechanism linking the two. One genetic factor may be altered oxidative-reductive capacity. This study tested the hypothesis that children with autism have increased oxidative stress. We evaluated children with autism for the presence of two oxidative stress biomarkers. Urinary excretion of 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-isoprostane-F2alpha (8-iso-PGF2alpha) were determined in 33 children with autism and 29 healthy controls. 8-iso-PGF2alpha levels were significantly higher in children with autism. The isoprostane levels in autistic subjects were variable with a bimodal distribution. The majority of autistic subjects showed a moderate increase in isoprostane levels while a smaller group of autistic children showed dramatic increases in their isoprostane levels. There was a trend of an increase in 8-OHdG levels in children with autism but it did not reach statistical significance. There was no significant correlation between the levels of the biomarkers and vitamin intake, dietary supplements, medicine, medical disorders, or history of regression. These results suggest that the lipid peroxidation biomarker is increased in this cohort of autistic children, especially in the subgroup of autistic children.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“oxidative stress might be a candidate mechanism linking genetic and environmental factors in genetic disorders associated with autism (149–151).”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [151]
In the citing paper
“There are presently several lines of evidence indicating oxidative stress and mitochondrial dysfunction are prevalent in individuals with ASD [3,10,11,12,13,14,15,16].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [10]
Citations
Cites
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Autism diagnostic interview: A standardized investigator-based instrument
Le Couteur, A., Rutter, M., Lord, C., Rios, P., Robertson, S., Holdgrafer, M., & McLennan, J. (1989) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02212936 · Cited by 1,036
James, S. J., Cutler, P., Melnyk, S., Jernigan, S., Janak, L., Gaylor, D. W., & Neubrander, J. A. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1611 · Cited by 955
Biomarkers of free radical damage
de Zwart, L. L., Meerman, J. H. N., Commandeur, J. N. M., & Vermeulen, N. P. E. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00196-8 · Cited by 854
The isoprostanes: Unique bioactive products of lipid peroxidation
Morrow, J. D., & Roberts, L. J. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00001-5 · Cited by 556
Chauhan, A., Chauhan, V., Brown, W. T., & Cohen, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.038 · Cited by 424
Oxygen Radicals in Biological Systems
(1984) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(00)x0131-0 · Cited by 417
Morrow, J. D., & Roberts, L. J. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)00106-8 · Cited by 409
Harrington, M. (1962) · Cited by 365
Ferritin as a source of iron for oxidative damage
Reif, D. W. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90091-t · Cited by 357
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Golse, 1978, Perturbation de deux enzymes; la superoxyde-dismutase I et la glutathione-peroxydase dans la psychose infantile de developpement (autisme infantile), Rev. Neurol. (Paris), 134, 699
- D. Shaffer, M. Campbell, S.J. Bradley, D.P. Cantwell, G.A. Carlson, D.J. Cohen, et al., Diagnostic and Statistical Manual of Mental Disorders, fourth ed., American Psychiatric Association, Washington, DC, 1994, pp. 65–78.
- Stein, 1996, nitrogen metabolism during spaceflight on the shuttle, J. Appl. Physiol., 81, 82, 10.1152/jappl.1996.81.1.82 · DOI
Cited by
Sorted by citations
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
Rossignol, D. A., & Frye, R. E. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.136 · Cited by 940
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Copper and Zinc, Biological Role and Significance of Copper/Zinc Imbalance
Osredkar, J. (2011) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.s3-001 · Cited by 648
Rossignol, D. A., & Frye, R. E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00150 · Cited by 382
Residential Proximity to Freeways and Autism in the CHARGE Study
Volk, H. E., Hertz-Picciotto, I., Delwiche, L., Lurmann, F., & McConnell, R. (2011) · Environmental Health Perspectives · doi:10.1289/ehp.1002835 · Cited by 347
The association of maternal obesity and diabetes with autism and other developmental disabilities
Li, M., Fallin, M. D., Riley, A., Landa, R., Walker, S. O., Silverstein, M., Caruso, D., Pearson, C., Kiang, S., Dahm, J. L., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2206 · Cited by 338
The isoprostanes—25 years later
Milne, G. L., Dai, Q., & Roberts, L. J. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.10.007 · Cited by 335
How environmental and genetic factors combine to cause autism: A redox/methylation hypothesis
Deth, R., Muratore, C., Benzecry, J., Power-Charnitsky, V.-A., & Waly, M. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.09.010 · Cited by 325
Oxidative Stress in Autism Spectrum Disorder
Bjørklund, G., Meguid, N. A., El-Bana, M. A., Tinkov, A. A., Saad, K., Dadar, M., Hemimi, M., Skalny, A. V., Hosnedlová, B., Kizek, R., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-019-01742-2 · Cited by 323
Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms
Tordjman, S., Somogyi, E., Coulon, N., Kermarrec, S., Cohen, D., Bronsard, G., Bonnot, O., Weismann-Arcache, C., Botbol, M., Lauth, B., et al. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00053 · Cited by 283
Melnyk, S., Fuchs, G. J., Schulz, E., Lopez, M., Kahler, S. G., Fussell, J. J., Bellando, J., Pavliv, O., Rose, S., Seidel, L., et al. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1260-7 · Cited by 250
Chauhan, A., Gu, F., Essa, M. M., Wegiel, J., Kaur, K., Brown, W. T., & Chauhan, V. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07189.x · Cited by 243
James, S. J., Melnyk, S., Fuchs, G. J., Reid, T., Jernigan, S., Pavliv, O., Hubanks, A., & Gaylor, D. W. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26615 · Cited by 241
Metabolic Perturbance in Autism Spectrum Disorders: A Metabolomics Study
Ming, X., Stein, T. P., Barnes, V., Rhodes, N., & Guo, L. (2012) · Journal of Proteome Research · doi:10.1021/pr300910n · Cited by 234
Self-citationJames, S. J., Rose, S., Melnyk, S., Jernigan, S., Blossom, S. J., Pavliv, O., & Gaylor, D. W. (2009) · The FASEB Journal · doi:10.1096/fj.08-128926 · Cited by 223
Metabolic biomarkers related to oxidative stress and antioxidant status in Saudi autistic children
Al-Gadani, Y., El-Ansary, A. K., Al-Attas, O., & AL-Ayadhi, L. Y. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.03.011 · Cited by 216
A novel function for fragile X mental retardation protein in translational activation
Bechara, E. G., Didiot, M. C., Melko, M., Davidovic, L., Bensaid, M., Martin, P., Castets, M., Pognonec, P., Khandjian, E. W., Moine, H., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000016 · Cited by 206
“Moreover, modifications of oxidative stress have been linked to anxiety [31], sleep troubles [32], and autism [33], all phenotypic characteristics displayed by Fragile X patients [34].”
BackgroundJahn, U., Galano, J., & Durand, T. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200705122 · Cited by 206
Goldani, A. A. S., Downs, S. R., Widjaja, F., Lawton, B., & Hendren, R. L. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00100 · Cited by 220
Xu, G., Jin, J., Bowers, K. A., Liu, B., & Bao, W. (2013) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-013-1928-2 · Cited by 216
Brain Region-Specific Glutathione Redox Imbalance in Autism
Chauhan, A., AUDHYA, T. K., & Chauhan, V. P. S. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0775-4 · Cited by 196
Classifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis
Erve, T. J. V. ‘., Kadiiska, M. B., London, S. J., & Mason, R. P. (2017) · Redox Biology · doi:10.1016/j.redox.2017.03.024 · Cited by 174
Autism and environmental genomics
Herbert, M. R., Russo, J. P., Yang, S., Roohi, J., Blaxill, M. F., Kahler, S. G., Cremer, L., & Hatchwell, E. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.03.017 · Cited by 167
Jung, C., Lin, Y.-T., & Hwang, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075510 · Cited by 170
Gu, F., Chauhan, V. P. S., Kaur, K., Brown, W. T., LaFauci, G., Węgiel, J., & Chauhan, A. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.68 · Cited by 160
Developmental neurotoxicity – Challenges in the 21st Century and In Vitro Opportunities
Smirnova, L. (2014) · ALTEX · doi:10.14573/altex.1403271 · Cited by 166
Ghanizadeh, A. J., & Sarani, E. M. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-196 · Cited by 158
Risk Factors for Unhealthy Weight Gain and Obesity among Children with Autism Spectrum Disorder
Dhaliwal, K. K., Orsso, C. E., Richard, C., Haqq, A. M., & Zwaigenbaum, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133285 · Cited by 157
Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders
Blaylock, R. L., & Strunecká, A. (2008) · Current Medicinal Chemistry · doi:10.2174/092986709787002745 · Cited by 138
Altered Vascular Phenotype in Autism
Yao, Y., Walsh, W. J., McGinnis, W. R., & Praticò, D. (2006) · Archives of Neurology · doi:10.1001/archneur.63.8.1161 · Cited by 131
Increase in Cerebellar Neurotrophin-3 and Oxidative Stress Markers in Autism
Sajdel-Sulkowska, E. M., Xu, M., & Koibuchi, N. (2009) · The Cerebellum · doi:10.1007/s12311-009-0105-9 · Cited by 122
Parletta, N., Niyonsenga, T., & Duff, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0156432 · Cited by 136
The multifaceted role of mitochondria in autism spectrum disorder
Khaliulin, I., Hamoudi, W., & Amal, H. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02725-z · Cited by 128
The Neurobiology of Lipid Metabolism in Autism Spectrum Disorders
Tamiji, J., & Crawford, D. A. (2010) · Neurosignals · doi:10.1159/000323189 · Cited by 116
N-Acetylcysteine as an Adjunctive Therapy to Risperidone for Treatment of Irritability in Autism
Nikoo, M., Radnia, H., Farokhnia, M., Mohammadi, M.-R., & Akhondzadeh, S. (2015) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000063 · Cited by 122
Vitamin D and Autism Spectrum Disorder: A Literature Review
Mazahery, H., Camargo, C., Conlon, C., Beck, K., Kruger, M., & Von Hurst, P. (2016) · Nutrients · doi:10.3390/nu8040236 · Cited by 110
Neurometabolic disorders and dysfunction in autism spectrum disorders
Zecavati, N., & Spence, S. J. (2009) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-009-0021-x · Cited by 110
James, S. J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D. W. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0614-2 · Cited by 107
Rossignol, D. A., Rossignol, L. W., James, S. J., Melnyk, S., & Mumper, E. A. (2007) · BMC Pediatrics · doi:10.1186/1471-2431-7-36 · Cited by 108
Mahler, H. I. M., Kulik, J. A., Harrell, J., Correa, A., Gibbons, F. X., & Gerrard, M. (2005) · Archives of Dermatology · doi:10.1001/archpedi.161.4.356 · Cited by 106
Status of essential elements in autism spectrum disorder: systematic review and meta-analysis
Saghazadeh, A., Ahangari, N., Hendi, K., Saleh, F., & Rezaei, N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0015 · Cited by 103
Oxidative stress in egyptian children with autism: Relation to autoimmunity
Mostafa, G. A., El-Hadidi, E. S., Hewedi, D. H., & Abdou, M. M. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.12.003 · Cited by 101
Pastural, É., Ritchie, S. A., Lu, Y., Jin, W., Kavianpour, A., Su-Myat, K. K., Heath, D., Wood, P. L., Fisk, M., & Goodenowe, D. B. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.06.003 · Cited by 101
Yorbık, Ö., Kurt, İ., Haşimi, A., & Öztürk, Ö. (2009) · Biological Trace Element Research · doi:10.1007/s12011-009-8494-7 · Cited by 99
Oxidative Stress in Autism: Elevated Cerebellar 3-nitrotyrosine Levels
Sajdel, E. M., Lipiński, B., Windom, H., AUDHYA, T. K., & McGinnis, W. R. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.73.84 · Cited by 101
Rossignol, D. A., Rossignol, L. W., Smith, S. A., Schneider, C., Logerquist, S., Usman, A., Neubrander, J., Madren, E. M., Hintz, G., Grushkin, B., et al. (2009) · BMC Pediatrics · doi:10.1186/1471-2431-9-21 · Cited by 97
Plasma fatty acid profiles in autism: A case-control study
Wiest, M. M., German, J. B., Harvey, D. J., Watkins, S. M., & Hertz‐Picciotto, I. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.01.007 · Cited by 97
Baj, J., Flieger, W., Flieger, M., Forma, A., Sitarz, R., Skórzyńska-Dziduszko, K., Grochowski, C., Maciejewski, R., & Karakuła‐Juchnowicz, H. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.07.029 · Cited by 100
Kaur, K., Chauhan, V. P. S., Gu, F., & Chauhan, A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.07.030 · Cited by 100
James, S. J., Melnyk, S., Jernigan, S., Hubanks, A., Rose, S., & Gaylor, D. W. (2008) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0591-5 · Cited by 96
Al-Yafee, Y. A., AL-Ayadhi, L. Y., Haq, S. H., & El-Ansary, A. K. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-139 · Cited by 93
Daughton, C. G. (2012) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2012.02.038 · Cited by 91
Gu, F., Chauhan, V. P. S., & Chauhan, A. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.021 · Cited by 88
Hunter, J. W., Mullen, G. P., McManus, J. R., Heatherly, J. M., Duke, A., & Rand, J. B. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003442 · Cited by 86
Anwar, A., Abruzzo, P. M., Pasha, S., Rajpoot, K., Bolotta, A., Ghezzo, A., Marini, M., Posar, A., Visconti, P., Thornalley, P. J., et al. (2018) · Molecular Autism · doi:10.1186/s13229-017-0183-3 · Cited by 86
Nadeem, A., Ahmad, S. F., AL-Ayadhi, L. Y., Attia, S. M., Al-Harbi, N. O., Alzahrani, K. S., & Bakheet, S. A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104554 · Cited by 81
Genetic variant of glutathione peroxidase 1 in autism
Ming, X., Johnson, W. G., Stenroos, E. S., Mars, A. E., Lambert, G. H., & Buyske, S. G. (2009) · Brain and Development · doi:10.1016/j.braindev.2008.12.017 · Cited by 80
Self-citationMetabolic biomarkers related to energy metabolism in Saudi autistic children
Al-Mosalem, O. A., El-Ansary, A. K., Al-Attas, O., & AL-Ayadhi, L. Y. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.04.006 · Cited by 80
Lipid mediators in plasma of autism spectrum disorders
El-Ansary, A. K., & AL-Ayadhi, L. Y. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-160 · Cited by 79
El-Ansary, A. K., Bacha, A. G. B., & Ayahdi, L. Y. A. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-63 · Cited by 79
HLA-DR4 as a Risk Allele for Autism Acting in Mothers of Probands Possibly During Pregnancy
Johnson, W. G., Buyske, S., Mars, A. E., Sreenath, M., Stenroos, E. S., Williams, T. A., Stein, R., & Lambert, G. H. (2009) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpediatrics.2009.74 · Cited by 77
Self-citationGriffiths, K. K., & Levy, R. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4314025 · Cited by 83
Felice, A. D., Greco, A., Calamandrei, G., & Minghetti, L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0617-4 · Cited by 81
Plasma phthalate and bisphenol a levels and oxidant-antioxidant status in autistic children
Kondolot, M., Ozmert, E. N., Ascı, A., Erkekoglu, P., Oztop, D. B., Gumus, H., Kocer-Gumusel, B., & Yurdakok, K. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.03.006 · Cited by 74
A comprehensive review of mercury provoked autism.
Geier, D. A., King, P. G., Sykes, L. K., & Geier, M. R. (2008) · PubMed · Cited by 74
Muratore, C., Hodgson, N., Trivedi, M. S., Abdolmaleky, H. M., Persico, A. M., Lintas, C., de la Monte, S. M., & Deth, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056927 · Cited by 74
Bradstreet, J. J., Smith, S. A., Baral, M., & Rossignol, D. A. (2010) · PubMed · Cited by 71
Raymond, L. J., Deth, R. C., & Ralston, N. V. C. (2014) · Autism Research and Treatment · doi:10.1155/2014/164938 · Cited by 68
Plasma antioxidant capacity is reduced in Asperger syndrome
Parellada, M., Moreno, C., MacDowell, K. S., Leza, J. C., Giráldez, M., Bailón, C., Castro, C., Miranda-Azpiazu, P., Fraguas, D., & Arango, C. (2012) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.10.004 · Cited by 68
Evans, T. A., Siedlak, S. L., Lu, L., Fu, X., Wang, Z., McGinnis, W. R., Fakhoury, E., Castellani, R. J., Hazen, S. L., Walsh, W. J., et al. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.61.72 · Cited by 68
Fatty acid compositions of red blood cell phospholipids in children with autism
Bu, B., Ashwood, P., Harvey, D., King, I. B., de Water, J. V., & Jin, L. W. (2006) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.02.001 · Cited by 66
Tordjman, S., Cohen, D., Anderson, G. M., Botbol, M., Canitano, R., Coulon, N., & Roubertoux, P. L. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.01.014 · Cited by 71
Urinary oxidative stress markers in children with autism
Damodaran, L. P. M., & Arumugam, G. (2011) · Redox Report · doi:10.1179/1351000211y.0000000012 · Cited by 64
Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism
Rossignol, D. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.064 · Cited by 65
Lipid biomarkers of oxidative stress in a genetic mouse model of Smith‐Lemli‐Opitz syndrome
Korade, Ž., Xu, L., Mirnics, K., & Porter, N. A. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-012-9504-z · Cited by 60
A Microscopic Study of Language-Related Cortex in Autism
Lopez-Hurt, E., & Prieto, J. J. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.130.145 · Cited by 60
Profiles of urine and blood metabolomics in autism spectrum disorders
Likhitweerawong, N., Thonusin, C., Boonchooduang, N., Louthrenoo, O., Nookaew, I., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00788-3 · Cited by 55
Oxidative stress response and NRF2 signaling pathway in autism spectrum disorder
Davinelli, S., Medoro, A., Siracusano, M., Savino, R., Saso, L., Scapagnini, G., & Mazzone, L. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103661 · Cited by 59
Animal model of autism using GSTM1 knockout mice and early post-natal sodium valproate treatment
Yochum, C. L., Bhattacharya, P., Patti, L. A., Mirochnitchenko, O., & Wagner, G. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.032 · Cited by 54
Self-citationMatsuo, K., Yabuki, Y., & Fukunaga, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107975 · Cited by 53
Mitochondrial Energy-Deficient Endophenotype in Autism
Gargus, J. J., & Imtiaz, F. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.198.207 · Cited by 53
Diagnostic and Severity-Tracking Biomarkers for Autism Spectrum Disorder
Bjørklund, G., Meguid, N. A., El-Ansary, A. K., El‐Bana, M. A., Dadar, M., Aaseth, J., Hemimi, M., Osredkar, J., & Chirumbolo, S. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1192-1 · Cited by 54
A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project
Smith, A. M., Natowicz, M. R., Braas, D., Ludwig, M. A., Ney, D. M., Donley, E. L. R., Burrier, R. E., & Amaral, D. G. (2020) · Autism Research · doi:10.1002/aur.2330 · Cited by 51
Isoprostanes and Related Compounds: Update 2006
Milne, G. L., & Morrow, J. D. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1379 · Cited by 51
Nadeem, A., Ahmad, S. F., Attia, S. M., AL-Ayadhi, L. Y., Al-Harbi, N. O., & Bakheet, S. A. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.020 · Cited by 50
El-Ansary, A. K., Cannell, J. J., Bjørklund, G., Bhat, R. S., Al-Dbass, A. M., Alfawaz, H., Chirumbolo, S., & AL-Ayadhi, L. Y. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0199-1 · Cited by 49
Rose, S., Wynne, R. A., Frye, R. E., Melnyk, S., & James, S. J. (2015) · Journal of Toxicology · doi:10.1155/2015/573701 · Cited by 46
Maternal Diabetes and Fetal Programming Toward Neurological Diseases: Beyond Neural Tube Defects
Márquez‐Valadez, B., Valle-Bautista, R., García-López, G., Díaz, N. F., & Molina‐Hernández, A. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00664 · Cited by 47
Altered Sulfur Amino Acid Metabolism In Immune Cells of Children Diagnosed With Autism
Suh, J. H., Walsh, W. J., McGinnis, W. R., Lewis, A. T., & Ames, B. N. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.105.113 · Cited by 45
A potential pathogenic role of oxalate in autism
Konstantynowicz, J., Porowski, T., Zoch-Zwierz, W. M., Wasilewska, J., Kądziela-Olech, H., Kułąk, W., Owens, S. C., Piotrowska-Jastrzębska, J. D., & Kaczmarski, M. G. (2011) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2011.08.004 · Cited by 42
A review of candidate urinary biomarkers for autism spectrum disorder
Wang, L., Angley, M. T., Gerber, C., & Sorich, M. J. (2011) · Biomarkers · doi:10.3109/1354750x.2011.598564 · Cited by 43
Knowles, E. E. M., Huynh, K., Meikle, P. J., Göring, H. H. H., Olvera, R. L., Mathias, S. R., Duggirala, R., Almasy, L. A., Blangero, J., Curran, J. E., et al. (2017) · European Psychiatry · doi:10.1016/j.eurpsy.2017.02.479 · Cited by 44
Zhu, J., Hua, X., Yang, T., Guo, M., Li, Q., Xiao, L., Li, L., Chen, J., & Li, T. (2021) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-021-05066-w · Cited by 44
Morales‐Suárez‐Varela, M., Peraita‐Costa, I., & González, A. L. (2016) · Environmental Research · doi:10.1016/j.envres.2016.11.022 · Cited by 45
Urinary Markers of Oxidative Stress in Children with Autism Spectrum Disorder (ASD)
Osredkar, J., Gosar, D., Maček, J., Kumer, K., Fabjan, T., Finderle, P., Šterpin, S., Zupan, M., & Vrhovšek, M. J. (2019) · Antioxidants · doi:10.3390/antiox8060187 · Cited by 40
Ilieva, M. S., Aldana, B. I., Vinten, K. T., Hohmann, S. S., Woofenden, T. W., Lukjanska, R., Waagepetersen, H. S., & Michel, T. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01627-2 · Cited by 37
Rice, J., & Kasprzyk‐Hordern, B. (2019) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2019.115621 · Cited by 37
DeSoto, M. C. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.03.003 · Cited by 37
Autism and EMF? Plausibility of a pathophysiological link – Part I
Herbert, M. R., & Sage, C. (2013) · Pathophysiology · doi:10.1016/j.pathophys.2013.08.001 · Cited by 37
Metadata
- Authors
- Ming, X., Stein, T. P., Brimacombe, M., Johnson, W. G., Lambert, G. H., & Wagner, G. C.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Rutgers New Jersey Medical School (US)
- Corresponding author
- Ming, X.
- Venue
- Prostaglandins, Leukotrienes and Essential Fatty Acids
- Publisher
- Elsevier BV
- Published
- 2005-11
- Volume
- 73
- Issue
- 5
- Pages
- 379-384
- ISSN
- 0952-3278 (ISSN-L)
- OpenAlex
- W2113611591
- Cited by
- 236
- References
- 44
- Citations by year
- 2025: 9 · 2024: 7 · 2023: 2 · 2022: 4 · 2021: 10 · 2020: 6 · 2019: 9 · 2018: 13 · 2017: 11 · 2016: 12 · 2015: 11 · 2014: 18 · 2013: 16 · 2012: 9
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Prostaglandins Leukotrienes and Essential Fatty Acids (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r21ns043981-03)
- National Institute of Neurological Disorders and Stroke (NS 43981)
- National Institute of Environmental Health Sciences (ES 11256, ES-05022., P01ES011256, P30ES005022)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
- Keywords
- autism spectrum disorder, oxidative stress, lipid peroxidation, 8-isoprostane, 8-hydroxy-2'-deoxyguanosine, urinary biomarkers, children, gene-environment interaction
- MeSH terms
- 8-Hydroxy-2'-Deoxyguanosine, Adolescent, Autistic Disorder, Child, Child, Preschool, Deoxyguanosine, Female, Humans, Male, Lipid Peroxidation, Dinoprost, Cohort Studies, Biomarkers, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review